SRRK · Scholar Rock Holding Corp
$55.25
-1.26 (-2.23%)
At close · Aug 20
Market Cap
$6.73B
Shares
121.79M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$55.25
Open$55.93
Day$54.84–56.75
52W close$27.92–57.94
Avg vol 30d1.1M
Short int17.7M · 14.5% float · 16.2d
Short vol48%
Last earningsAug 6, 2026
DataJan 2020–Aug 2026
Filing10-Q · Aug 6
Up next
Next earnings call
Nov 10, 2026
Est · unconfirmed
· in 12 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 6, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Strong Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+19%
above
Price vs 50-day avg
+8%
above
RSI (14)
60
neutral
MACD trend
Positive
52-week position
91%
near high
Momentum
relative strength
1-month return
+12%
trailing
6-month return
+25%
trailing
YTD return
+25%
this year
Relative strength
+14%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $51 › 200d $46 — 50d above 200d
Institutional flow
Accumulating
+9% holders QoQ · +57 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
14.51% of float · ▲ +0.4% MoM · 16.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
306 holders — near 3-yr high, broad support
Squeeze score
75
high risk · 0–100
Fundamentals
EPS growth
−33%
Y/Y
Free cash flow
$-300.6M
Balance sheet
$223.2M
net cash
Quant / Vol
risk profile
Volatility
61%
annualized · 1-yr
Max drawdown
−32%
past year
ATR
4.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+19%
Bullish
Price vs 50-day avg
+8%
Bullish
RSI (14)
60
Neutral
MACD trend
Positive
Bullish
52-week position
91%
Bullish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $51 › 200d $46 — 50d above 200d
Institutional flow
Accumulating
+9% holders QoQ · +57 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
14.51% of float · ▲ +0.4% MoM · 16.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
306 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $28
Now $55 · 91%
Range high $58
vs 200-day avg +19%
vs 50-day avg +8%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SRRK
this stock
Scholar Rock Holding Corp
|
$6.73B | +25.4% | — | — | 14.5% |
|
ONC
BeOne Medicines Ltd.
|
$557.05B | +21.5% | +22179.2% | 856.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$136.93B | +19.2% | +46.2% | 31.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$86.39B | +7.1% | +20.8% | 20.8 | 3.3% |
|
MRNA
Moderna, Inc.
|
$69.62B | +352.1% | +4.3% | — | 12.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SRRK | +4.1% | +11.7% | +24.8% | +16.8% | +25.4% |
| SPY | -2.0% | +3.3% | +11.2% | +2.1% | +11.8% |
| vs SPY | +6.1% | +8.4% | +13.6% | +14.7% | +13.6% |
Key facts
CIK
1727196
CUSIP
80706P103
13F (30d)
287 filings
283 filers
Visit website
Investor relations